Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,924.66 +891.04 (+1.41%) CMC Crypto 200
1,327.24 +50.26 (+3.94%)
Novartis AG (NVSEF)
| Previous close | 97.00 |
| Open | 94.74 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 94.74 - 94.74 |
| 52-week range | 90.12 - 109.00 |
| Volume | |
| Avg. volume | 43,791 |
| Market cap | 197.27B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 21.53 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.76 (3.97%) |
| Ex-dividend date | 07 Mar 2024 |
| 1y target est | N/A |
- Zacks
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
- Reuters SG
Deals of the day-Mergers and acquisitions
** Commodities group Glencore is studying an approach for Anglo American, two sources said, a development that could spark a bidding war for the 107-year old mining company. ** U.S. private equity firm Bain Capital is looking at buying some key assets of French tech and software company Atos , reported French paper Les Echos on its website, citing sources.
- Reuters
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday. Mariana Oncology is working on novel radioligand cancer therapies (RLTs) that have not yet been tested on humans. "The transaction bolsters the Novartis RLT pipeline and expands the company’s research infrastructure and clinical supply capabilities," Novartis said in a statement.
